Metraipolis › archive › dc_676a9747fc6f

Immunogenicity of a CXCL8-based biopharmaceutical drug candidate in comparison to its wildtype form — Europe PMC PMID:41476988

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41476988
DOI
10.3389/fimmu.2025.1679409
License (as archived)
solo-consultazione
Archived
2026-11-07T14:39:48.006Z
SHA-256 of the archived text
97405aa84af1f4ab0080fb091ce32b8a3dfbccad51c3b7cff702d2016409d88d
Stable URL of this page
https://metraipolis.com/documento/dc_676a9747fc6f

How to cite

Immunogenicity of a CXCL8-based biopharmaceutical drug candidate in comparison to its wildtype form — Europe PMC PMID:41476988 — Europe PMC (en), https://europepmc.org/article/MED/41476988 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_676a9747fc6f (Metraipolis archive dc_676a9747fc6f, sha256 97405aa84af1f4ab0080fb091ce32b8a3dfbccad51c3b7cff702d2016409d88d)
BibTeX
@misc{dc676a9747fc6f,
  title = {Immunogenicity of a CXCL8-based biopharmaceutical drug candidate in comparison to its wildtype form — Europe PMC PMID:41476988},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41476988},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_676a9747fc6f; sha256 97405aa84af1f4ab0080fb091ce32b8a3dfbccad51c3b7cff702d2016409d88d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41476988. Agents can read the archived copy with the MCP tool read_document.